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In the brain, TRPC1 channels are abundantly expressed in neurones virtually in all
regions; these proteins function as receptor-activated ion channels and are implicated in
numerous processes, being specifically important for neurogenesis. Primary cultures of
mouse cerebellar granule cell, cerebral cortical neurones, and freshly isolated neurones
from in vivo brains were used to study effects of chronic treatment with anti-bipolar drugs
[carbamazepine (CBZ), lithium salts and valproic acid] on gene expression of TRPC1.
Expression of TRPC1 mRNA was identified with reverse transcription-polymerase chain
reaction, whereas protein content was determined by Western blotting. Store-operated
plasmalemmal Ca2+ entry (SOCE) was measured with fura-2 based microfluorimetry.
Chronic treatment with each of the three drugs down-regulated mRNA and protein
expression in cultured cerebellar granule cells in a time- and concentration-dependent
manner. Similar effect was also observed in cultured cerebral cortical neurones treated
with CBZ, lithium salts and valproic acid and in freshly isolated neurones from the
brains of CBZ-treated animals. The amplitude of SOCE was substantially decreased
in cerebellar granule cells chronically treated with each of the three drugs. Our findings
indicate that down-regulation of TRPC1 gene expression and function in neurones may
be one of the mechanisms of anti-bipolar drugs action.
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INTRODUCTION
Bipolar disorder (BD) is a common, devastating and chronic mental disease that affects 1–3% of the
population (Goodwin and Jamison, 2007). Carbamazepine (CBZ), lithium salts (Li+), and valproic
acid (VPA) are the three classical anti-bipolar drugs. However, despite being in clinical use for
several decades, the mechanisms underlying their therapeutic effects remain elusive. Given CBZ,
Li+, and VPA share no similarity in chemical structures, revealing downstream effects of all three
drugs is important for further understanding drug targets and the pathophysiology of the disease.
We have found several genes that are regulated by chronic treatment with anti-bipolar drugs in
astrocytes (for review, see Peng et al., 2016). These includes down-regulation of gene expression of
glutamate kainate receptor GluK2 (Li et al., 2009), the Ca2+-dependent phospholipase A2 (Li et al.,
2007) and transient receptor potential channel 1 (TRPC1); a cation channel, which in astroglia is
activated by ER store depletion and contributes to the store-operated Ca2+ entry, SOCE (Yan et al.,
2013).
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TRPC1 channels are abundantly expressed in all regions of
the brain, including cortex, hippocampus, cerebellum, forebrain,
brain stem and basal ganglia (Riccio et al., 2002; Martorana
et al., 2006; Narayanan et al., 2008 and see Vennekens et al.,
2012 for comprehensive review). In the early neurogenesis
TRPC1 channels have been proven to be critical, because
they control proliferation of adult neural progenitor cell, and
genetic deletion of TRPC1 significantly reduced proliferation rate
of these progenitors. Importantly the contribution of TRPC1
to regulation of proliferation was directly linked to TRPC1-
mediated SOCE (Li et al., 2012). In addition TRPC1 (together
with TRPC5 and TRPC6) regulate neurite extension, most likely
through fine tuning Ca2+ signals in the growth cone (Vennekens
et al., 2012).
We are therefore, interested in whether canonical anti-
bipolar drugs have effect on TRPC1 gene expression in
neurones. In the present paper, we report experiments on
primary cultures of mouse cerebellar granule neurones, cerebral
cortical neurones, and freshly isolated neurones from transgenic
mice expressing a fluorescent neurone-specific marker used
for fluorescence-activated sorting (FACS). Cerebellar granule
cells represent a well-established, well-differentiated model for
studying glutamatergic signaling (Gallo et al., 1987; Marini
et al., 1989; Peng et al., 1991; Bak et al., 2003); granule
neurones express NMDA, AMPA and metabotropic glutamate
receptors, and they are vulnerable to excitotoxic insults
(Condorelli et al., 1993; Lavreysen et al., 2005). Cerebral
cortical neurones are GABAergic and also sensitive to glutamate
excitotoxicity mediated by NMDA receptors (Chuang et al.,
2002), whereas in experiments in vivo analysis was mainly
restricted to large projection neurones which express Thy1
promoter. We studied: (i) effects of chronic treatment with
anti-bipolar drugs on mRNA and protein expression of TRPC1
in primary cultures of cerebellar granule neurones; (ii) effects
of chronic treatment with anti-bipolar drugs on mRNA and
protein expression of TRPC1 in primary cultures of cerebral
cortical neurones; (iii) expression of TRPC1 mRNA in FACS-
isolated neurones from animals treated with daily injections of
CBZ, and (iv) effects of chronic treatment with anti-bipolar
drugs on SOCE in primary cultures of cerebellar granule
cells.
MATERIALS AND METHODS
Animals
Male B6.Cg-Tg(Thy1-YFPH)2Jrs/J mice (from The Jackson
Laboratory, Bar Harbor, ME, USA), weighing 20–25 g were
housed in cages on a 12 h light/dark cycle in a temperature-
controlled (23–25◦C) colony room with free access to food
and water. These transgenic mice express fluorescent neurone-
specific marker, allowing fluorescence-activated sorting of
specified cell fractions, although it should be emphasized that
Thy1 is mainly a marker of large projection neurones rather
than a general neuronal marker (Feng et al., 2000; Seki et al.,
2002). All experiments were carried out in accordance with the
USA National Institute of Health Guide for the Care and Use
of Laboratory Animals (NIH Publications No. 80-23) revised
1978, and all experimental protocols were approved by the
Institutional Animal Care and Use Committee of China Medical
University.
Cell Cultures
Cerebellar granule cells were cultured as previously described
(Peng et al., 1991) with minor modifications. Briefly, 7- day-old
mouse pups were rapidly decapitated and the brains taken out.
The cerebella were aseptically separated from the remainder of
the brain, and after removal of the meninges, the tissue was cut
into cubes of −0.4 mm side dimensions, exposed to trypsin in
a Ca2+/Mg2+-free salt solution, reintroduced into tissue culture
medium, passed through nylon sieves and seeded into polylysine
coated standard 35-mm tissue culture dishes (Wuzhou Medical
Plastic Factory, Zhejiang, China), using one cerebellum per
culture dish. The cultures were grown in Dulbecco’s medium in
which the glucose concentration was increased to 30 mM and
the K+ concentration to 24.5 mM, the glutamine concentration
was decreased to 0.8 mM and 7% horse serum was added.
The elevation of the K+ concentration is necessary for normal
development of the cells (Gallo et al., 1987) and more specifically
for normal dendritic development and for release of transmitter
glutamate (Peng et al., 1991). After 2 days, cytosine arabinoside
was added to the medium to a final concentration of 40 µM
to curtail astrocytes growth. The cells were used at the age of
7–8 days at which time they have reached maturity (Peng et al.,
1991).
Cerebral cortical neurones were prepared by a similar method
as the cerebellar granule neurones (Hertz et al., 1989) except that
cortical hemispheres from 14-day-old mouse embryos were used
as the source of the cultures and that the cultures were grown
in normal tissue culture medium with 5.4 mM K+ and 2 mM
glutamine. The cultures were used at 8–10 days of age when they
have developed characteristics of mature cortical interneurones
(Schousboe and Hertz, 1987).
Drug Treatment
Adult mice were daily injected intraperitoneally with CBZ
[25 mg/kg/d dissolved in 0.9% NaCl (Rao et al., 2007)] or
saline for 3 or 7 days. Three days after plating primary cultures
of cerebellar granule cells and cerebral cortical neurones were
treated with CBZ, lithium carbonate or VPA for either 3 or 7 days.
Preparation of Freshly Isolated Cells
Immediately after decapitation, cerebral hemispheres (without
olfactory bulbs and hippocampi) were removed. The remaining
parts of the brains were placed in cold Hanks buffer containing
glutamate receptor antagonists (3 µM DNQX and 100 µM
APV), cut into small pieces, and digested with 8 U/ml papain
in Ca2+/Mg2+-free PIPES/cysteine buffer, pH 7.4, for 1 h at
37◦C in a humidified atmosphere of CO2/air (5:95%). After one
wash, the tissue was further digested with 40 U/ml DNase I
in Mg2+-containing minimum essential medium (MEM) with
1% bovine serum albumin (BSA) for 15 min at 37◦C in a
humidified atmosphere of CO2/air (5:95%). It was then carefully
triturated in cold MEM with 1% BSA, and centrifuged over a
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90% Percoll gradient, followed by collection of all cells below
and including the lipid layer. This suspension was further diluted
five times, with MEM containing 1% BSA, and centrifuged
to collect the pellet. Immediately thereafter, the cells were re-
suspended in cold MEM with 1% BSA and 4 µg/ml propidium
iodide and sorted by FACS using the BD FACSAria Cell
Sorting System (35 psi sheath pressure, FACSDiva software S/W
2.2.1; BD Biosciences, San José, CA, USA) as described by
Lovatt et al. (2007). YFP were excited by a 488 nm laser, and
emissions were collected by 530 nm discrimination filters. Since
a relatively small amount of cells was obtained following FACS-
separation we performed only mRNA detection. Cell identity
and purity were verified by mRNA expression of cell markers of
astrocytes, neurones and oligodendrocytes, analyzed by reverse-
transcription polymerase chain reaction (RT-PCR), in astrocytic
and neuronal cell preparations. As shown by Fu et al., 2012 there
is no contamination with neuronal or oligodendrocytic genes
in the samples of astrocytes or of astrocytic or oligodendrocytic
genes in the neuronal samples.
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
For determination of mRNA expression by RT-PCR, a cell
suspension was prepared by discarding the culture medium,
adding Trizol to cultures on ice, and scraping the cells off the
culture dish. The RNA pellet was precipitated with isopropanol,
washed with 70% ethanol, and dissolved in 10 µl sterile, distilled
water, and an aliquot was used for determination of the amount
of RNA (Kong et al., 2002).
Reverse-transcription was initiated by a 5 min-incubation
at 65◦C of 1 µg RNA extract with Random Hexamer at
a final concentration of 12.5 ng/l and deoxy-ribonucleoside
triphosphates (dNTPs) at a final concentration of 0.5 mM. The
mixture was rapidly chilled on ice and briefly spun, and 4 µl 5×
First-Strand Buffer, 2 µl 0.1 M dithiotreitol and 1 µl RNaseOUT
Recombinant RNase Inhibitor (40 U/µl) were added. After the
mixture had been incubated at 42◦C for 2 min, 1 µl (200 U) of
Superscript II was added, and the incubation at 42◦C continued
for another 50 min. Subsequently, the reaction was inactivated
by heating to 70◦C for 15 min, and the mixture was chilled and
briefly centrifuged.
Polymerase chain reaction (PCR) amplification was
performed in a Robocycler thermocycler with 0.2 µM
of sense or antisense and 0.375 U of Taq polymerase for
TRPC1 (forward, CCTTCTCATACTGTGGATTATTG; reverse,
GTACCAGAACAGAGCAAAGCA) (Ng et al., 2009), and for
TATA box-binding protein (TBP), used as a housekeeping
gene (forward, CCACGGACAACTGCGTTGAT; reverse,
GGCTCATAGCTACTGAACTG) (el-Marjou et al., 2000),
designed and purchased form Sangon Company (Shanghai,
China). Initially the template was denatured by heating to
94◦C for 2 min, followed by 2.5 min amplification cycles, each
consisting of two 45-s periods and one 60-s period, the first
at 94◦C, the second at 58◦C for TRPC1 and at 55◦C for TBP,
and the third at 72◦C. The final step was extension at 72◦C for
10 min. The PCR products were separated by 1% agarose gel
electrophoresis, stained with 0.5 µg/ml ethidium bromide, and
captured by Fluorchem 5500 (Alpha Innotech Corporation, San
Leandro, CA, USA).
Western Blotting
Protein content was determined by the Lowry method (Lowry
et al., 1951), using BSA as the standard. Samples containing
100 µg protein for TRPC1 or 20 µg for β-actin were applied
on slab gels of 10% polyacrylamide and electrophoresed. After
transfer to polyvinylidene fluoride (PVDF) membranes, the
samples were blocked by 5% skim milk powder in TBS-T
(30 mM Tris-HCl, 125 mM NaCl, 0.1% Tween 20) for 1 h.
The PVDF membranes were incubated with the first antibody,
specific to TRPC1 overnight at 4◦C, or β-actin for 2 h at
room temperature. After washing, the blots were incubated with
peroxidase-conjugated affinity-purified goat-anti-mouse or goat-
anti-rabbit horseradish antibody for 2 h. Staining was visualized
by ECL detection reagents. Digital images obtained using Gel-
Imaging System (Tanon, 4200, Shanghai). Optical density for
each band was assessed using the Window Alpha-Ease TM FC
32-bit software.
Monitoring of Intracellular Ca2+
Concentration
For [Ca2+]i recordings an Olympus IX71 live cell imaging
fluorescence microscope (Tokyo, Japan) was used to monitor
fluorescence intensity of Fura-2 loaded cultured neurones. For
Fura-2/AM loading the growth medium was replaced with saline
solution (137 mM NaCl, 5 mM KCl, 0.44 mM KH2PO4, 4 mM
NaHCO3, 1.3 mM CaCl2, 0.8 mM MgSO4, and 0.5 mM MgCl2
with 10 mM glucose) containing 5 µM Fura-2/AM for 30 min
at 37◦C. After two times wash with similar saline, the coverslip
was perfused with the saline solution, and recordings were
made at 340 and 380 nm excitation and 510 nm emission
wavelengths at 15 s intervals. The data are presented as 340/380
ratio R normalized to 340/380 ratio reading at the rest (R0).
The SOCE was assessed by measuring the amplitude of [Ca2+]i
transient induced by re-addition of extracellular Ca2+ to cells
pre-incubated with Ca2+-free buffer in combination with the
SERCA inhibitor thapsigargin. Twenty cells were selected in
each coverslip, and three coverslips were averaged in each
experimental group.
Materials
Chemicals for preparation of culturing medium were purchased
from Sigma (St. Louis, MO, USA) and horse serum from
Invitrogen (Carlsbad, CA, USA). Most chemicals, including
CBZ, VPA, 4-CML (4-chloro-3-methylphenol) and thapsigargin
were purchased from Sigma (St. Louis, MO, USA). Lithium
carbonate (Li2CO3) was obtained from Shanghai Hengxin
Chemical Reagent (Shanghai, China). TRPC1 antibody (ACC-
010) was obtained from Alomone Labs (Jerusalem, Israel).
Antibody specific to β-actin (A5441) was obtained from
Sigma-Aldrich (St. Louis, MO, USA). Goat-anti-rabbit IgG
HRP conjugate was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Goat-anti-mouse IgG HRP conjugate
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FIGURE 1 | Down-regulation of mRNA and protein expression of TRPC1 by chronic treatment with carbamazepine (CBZ) in primary cultures of
mouse cerebellar granule cells. Cells were treated with PBS (control) or with 25 or 50 µM CBZ for 3 or for 7 days. (A) Southern blot from a representative
experiment. Similar results were obtained from three independent experiments. Average mRNA expression was quantified as a ratio between TRPC1 and TBP, as a
housekeeping gene. The size of the PCR product of TRPC1 is 517 bp and that of TBP 236 bp. SEM values are indicated by vertical bars. ∗Statistically significant
(p < 0.05) difference from control group. (B) Immunoblot from a representative experiments. Similar results were obtained from three independent experiments.
Average protein expression was quantified as a ratio between TRPC1 and β-actin. SEM values are indicated by vertical bars. ∗Statistically significant (p < 0.05)
difference from control group.
was obtained from Promega (Madison, WI, USA). Fura-
2 AM was obtained from Invitrogen (Carlsbad, CA, USA).
Random Hexamer and Taq-polymerase for RT-PCR were
purchased from TaKaRa Biotechnology, Co., Ltd (Dalian,
China).
Statistics
All statistical comparisons between groups were performed by
Student’s t-test. Levels of significance were expressed as P-values.
RESULTS
Gene Expression of TRPC1
Chronic treatment of cultured cerebellar granule neurones with
CBZ decreased mRNA and protein expression of TRPC1 in a
time- and concentration-dependent manner (Figure 1). Seven
days of treatment with CBZ at 25 µM down-regulated of mRNA
expression of TRPC1 whereas 3 days of treatment had no effect.
However, CBZ at 50 µM caused a significant down-regulation
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FIGURE 2 | Down-regulation of mRNA and protein expression of TRPC1 by chronic treatment with lithium in primary cultures of mouse cerebellar
granule cells. Cells were treated with PBS (control) or with 0.5 or 1 mM lithium for 3 or 7 days. (A) Southern blot from a representative experiment. Similar results
were obtained from three independent experiments. Average mRNA expression was quantified as a ratio between TRPC1 and TBP, as a housekeeping gene. The
size of the PCR product of TRPC1 is 517 bp and that of TBP 236 bp. SEM values are indicated by vertical bars. ∗Statistically significant (p < 0.05) difference from
control group. (B) Immunoblot from a representative experiments. Similar results were obtained from three independent experiments. Average protein expression
was quantified as a ratio between TRPC1 and β-actin. SEM values are indicated by vertical bars. ∗Statistically significant (p < 0.05) difference from control group.
of TRPC1 mRNA after 3 days (54 ± 4.1%) with further decline
after 7 days [45 ± 4.6% of control group (Figure 1A)]. Protein
expression of TRPC1 was unaffected by both 3 and 7 days of
treatment with 25µM CBZ, but after 3 or 7 days of treatment with
50 µM CBZ it decreased significantly to 37± 9.1 and 30± 3.9%,
respectively when compared to the control group (Figure 1B;
originals of blots are presented in Supplementary Figure S1).
Similar effect was also observed in cells treated with lithium
carbonate or VPA (Figures 2 and 3). Exposure to 0.5 mM
Li+ did not affect TRPC1 expression neither after 3 nor after
7 days, whereas a decrease in expression to 61 ± 3.4% of control
group was observed at 1 mM Li+ after 7 days (Figure 2A).
Protein expression of TRPC1 has not changed after 3 as well
as after 7 days of treatment with 0.5 mM Li+. However, after
7 days of treatment with 1 mM Li+, protein expression of
TRPC1 significantly decreased to 31± 6.9% compared to control
(Figure 2B). Similarly, exposure to 100 µM VPA had no effect,
whereas in the presence of 1 mM VPA, mRNA expression of
TRPC1 decreased to 55 ± 5.5 and 51 ± 5.8% of control group
after 3 and 7 days, respectively (Figure 3A). The TRPC1 protein
was similarly down-regulated in the presence of 1 mM VPA after
3 days to 40± 8.3% of control group and after 7 days to 39± 4.1%
of control group, although no effect was detected at 100 µM of
VPA after 3 and 7 days (Figure 3B).
In order to see whether the effect of anti-bipolar drugs is
restricted to cerebellar granule cells, we analyzed the effect of
CBZ, lithium carbonate or VPA on TRPC1 gene expression
in cultured cerebral cortical neurones. Treatment of cultured
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FIGURE 3 | Down-regulation of mRNA and protein expression of TRPC1 by chronic treatment with VPA in primary cultures of mouse cerebellar
granule cells. Cells were treated with PBS (control) or with 100 µM or 1 mM VPA for 3 or 7 days. (A) Southern blot from a representative experiment. Similar results
were obtained from three independent experiments. Average mRNA expression was quantified as a ratio between TRPC1 and TBP, as a housekeeping gene. The
size of the PCR product of TRPC1 is 517 bp and that of TBP 236 bp. SEM values are indicated by vertical bars. ∗Statistically significant (p < 0.05) difference from
control group. (B) Immunoblot from a representative experiments. Similar results were obtained from three independent experiments. Average protein expression
was quantified as a ratio between TRPC1 and β-actin. SEM values are indicated by vertical bars. ∗Statistically significant (p < 0.05) difference from control group.
cerebral cortical neurones with 50 µM CBZ induced a decrease of
TRPC1 mRNA expression to 57 ± 2.1 and 47 ± 2.0% of control
group after 3 and 7 days, respectively. Protein expression of
TRPC1 similarly decreased to 39 ± 1.8 and 35 ± 2.5% compared
to control after 3 and 7 days of treatment (Figure 4A). Exposure
to 1 mM lithium carbonate decreased TRPC1 mRNA expression
to 68 ± 2.1% of control group after 7 days. Protein expression
of TRPC1 similarly decreased to 47 ± 3.5% compared to control
after 7 days of treatment (Figure 4B). Treatment with 1 mM VPA
decreased TRPC1 mRNA expression to 51± 1.6 and 49± 2.2% of
control group after 3 and 7 days, respectively. Protein expression
of TRPC1 was similarly decreased to 47 ± 7.6 and 32 ± 5.8%
compared to control after 3 and 7 days of treatment (Figure 4C).
In addition, comparable decrease in TRPC1 mRNA expression
was observed in neurones freshly isolated from the brains of CBZ
treated mice; mRNA was decreased to 61± 5.2 and 52± 2.0% of
control group after 3 and 7 days, respectively (Figure 5).
Store-Operated Ca2+ Entry
The decrease of TRPC1 gene expression in cerebellar granule cells
chronically treated with CBZ was associated with the decrease
in the amplitude of SOCE (Figure 6A). To analyze the SOCE
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FIGURE 4 | Down-regulation of mRNA and protein expression of TRPC1 by chronic treatment with CBZ, Li+, or VPA in primary cultures of mouse
cerebral cortical neuron. (A) Cells were treated with PBS (control) or with 50 µM CBZ for 3 or 7 days. (B) Cells were treated with PBS (control) or with1 mM Li+
for 3 or 7 days. (C) Cells were treated with PBS (control) or with 1 mM VPA for 3 or 7 days. The representative Southern blot and immunoblot are shown. Similar
results were obtained from three independent experiments. Average mRNA expression was quantified as a ratio between TRPC1 and TBP, as a housekeeping gene.
The size of the PCR product of TRPC1 is 517 bp and that of TBP 236 bp. Average protein expression was quantified as ratios between TRPC1 and β-actin. SEM
values are indicated by vertical bars. ∗Statistically significant (p < 0.05) difference from control group.
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FIGURE 5 | CBZ induced down-regulation of mRNA and protein
expression of TRPC1 in neurones isolated by FACS from cerebral
hemisphere in vivo from mice. Adult [B6.Cg-Tg(Thy1–YFPH)2Jrs/J] mice
were treated with either saline (control) or CBZ (25 mg/kg/day) dissolved in
saline for 3 or 7 days. Average mRNA expression was quantified as a ratio
between TRPC1 and TBP, as a housekeeping gene. The size of the PCR
product of TRPC1 is 517 bp and that of TBP 236 bp. Similar results were
obtained from three independent experiments. SEM values are indicated by
vertical bars. ∗Statistically significant (p < 0.05) difference from control group.
cells were incubated in Ca2+-free buffer with 1 µM thapsigargin
for 10 min. Thereafter Ca2+ (2 mM) was re-introduced into
the incubation buffer, this triggering [Ca2+]i transient mediated
by the SOCE pathway. Of note, the SOCE was not affected
by inhibitors of voltage-gated Ca2+ channels (Supplementary
Figure S2), indicating that SOCE-associated cell depolarisation
did not exceed the threshold of Ca2+ channels activation. The
amplitude of [Ca2+]i transient associated with SOCE decreased
by ∼55% (0.1894 ± 0.0290 in control vs. 0.0857 ± 0.0228 in
CBZ treated cells, n = 60, p < 0.05) after 3 days and by ∼58%
(0.3217 ± 0.0394 in control vs. 0.1361 ± 0.0313 in CBZ treated
cells, n = 60, p < 0.05) after 7 days of treatment with 50 µM
CBZ (Figure 6A). Treatment with 1 mM Li+ for 3 days had
no effect on SOCE, after 7 days, however. SOCE decreased by
55% (0.2367 ± 0.0283 in control vs. 0.1055 ± 0.0255 in Li+
treated cells, n = 60, p < 0.05) (Figure 6B). The amplitude
of [Ca2+]i transient associated with SOCE decreased by ∼64%
(0.2479 ± 0.0205 in control vs. 0.0899 ± 0.0188 in VPA
treated cells, n = 60, p < 0.05) after 3 days and by ∼57%
(0.2367 ± 0.0283 in control vs. 0.1008 ± 0.0263 in VPA treated
cells, n = 60, p < 0.05) after 7 days of treatment with 1 mM
VPA (Figure 6C). In both control and drug-treated cells, [Ca2+]i
elevation induced by the SERCA inhibitor thapsigargin at 1 µM
was not detectable.
DISCUSSION
A large body of evidence indicates that the resting and stimulated
levels of [Ca2+]i are elevated in BD (Wasserman et al., 2004
and references therein). It has been noted also that several
mood stabilizers affect intracellular Ca2+ dynamics in various
neuronal cells. For example, CBZ inhibits NMDA-evoked Ca2+
influx in rat cerebellar granule cells (Hough et al., 1996),
while long-term Li+ treatment attenuates NMDA receptor-
mediated Ca2+ entry in primary cultures of rat cerebellar
granule cells (Nonaka et al., 1998) and glutamate-mediated Ca2+
signaling in hippocampal neurones (Sourial-Bassillious et al.,
2009). Significant reduction of the low-threshold Ca2+ current
has been observed in rat nodose neurones treated with valproic
acid (Kelly et al., 1990). Our present findings suggest that
down-regulation of TRPC1 gene expression may be one of the
mechanisms of drug action on intracellular Ca2+ dynamics in
neurones.
Firstly, we found that chronic treatment with all three anti-
bipolar drugs, CBZ, Li+ and VPA, down-regulated mRNA and
protein expression of TRPC1 in a concentration-dependent
manner. CBZ at lower concentration (25 µM) decreased TRPC1
gene expression after 7 days of treatment but had no effect
after 3 days of treatment. However, both Li+ and VPA at lower
concentrations (0.5 mM and 100 µM) had no effect in the time
period used in the present study. This effect of drugs seems
to be independent from the type of neurones. In the present
work, we have observed the decrease of TRPC1 expression
in cultured cerebellar granule cells, cultured cerebral cortical
neurones and freshly isolated neurones from the brains in vivo.
Previously, we reported similar drug effect in astrocytes (Yan
et al., 2013). Secondly, we found a substantial decrease in the
SOCE in cerebellar granule cells exposed to each of the three
drugs. TRPC1 channels control several aspects of cytosolic ion
signaling due to their polyionic permeability, as in physiological
conditions TRPC1 channels provide both Ca2+ and Na+ influx
(Reyes et al., 2013). In astrocytes, the TRPC1 protein has been
implicated in exocytotic release of glutamate (Parpura et al.,
2011).
It has been suggested that TRPC1 are positioned downstream
of glutamate metabotropic receptors (mGluRs) and NMDA
receptors in neurones. It is of interest because overactivity of
glutamatergic system in BD has been documented (Chen et al.,
2010), and regulation of TRPC1 function by glutamate receptors
may contribute to the pathophysiology of the disease. It has
been reported that TRPC1 channels localize in perisynaptic
regions of the cerebellar parallel fiber-Purkinje cell synapse where
they are physically and functionally coupled with the mGluR1
to induce a slow excitatory post-synaptic conductance (EPSC)
(Kim et al., 2003). Knocking down TRPC1 using TRPC1-shRNA
or blocking TRPC1 channels reduced glutamate-induced and
mGluR5-mediated cell death in murine hippocampal cell line
HT22 (Narayanan et al., 2014). The large depolarizing plateau
potential which is essential for the epileptiform burst firing by
metabotropic glutamate receptors was reduced by 74% in septal
neurones of TRPC1−/− mice compared to WT mice (Phelan
et al., 2012). In olfactory bulb granule cells TRPC1, as well
as TRPC4, can be activated downstream of NMDA receptors
and contribute to slow dendritic GABA release (Stroh et al.,
2012). These findings suggest that TRPC1 contributes to multiple
signals instigated by activation of glutamate receptors, and a
decrease of TRPC1 expression and function by anti-bipolar
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FIGURE 6 | Effect of chronic treatment with CBZ, lithium or VPA on store-operated Ca2+ entry in primary cultures of mouse cerebellar granule cells.
Cells were treated with CBZ (50 µM), lithium (1 mM), or VPA (1 mM) for 3 or 7 days. After loading with fura-2 AM for 30 min, cells were incubated in Ca2+-free buffer
with 1 µM thapsigargin, an inhibitor of SERCAs. After 10 min Ca2+ (2 mM) was re-introduced into the incubation buffer. (A–C) Representative traces show the
averaged changes in [Ca2+]i (normalized with the R/R0 ratio at the 0 time; each representative trace shows the average changes in [Ca2+]i of three individual
experiments; 20 cells per experiment). Mean of peak amplitudes of SOCE-associated [Ca2+]i peak. SEM values are indicated by vertical bars. ∗Shows statistically
significant (p < 0.05) difference from control group.
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drugs may overcome of the abnormal overactivity of glutamate
receptors that develops in BD.
CONCLUSION
We demonstrated, for the first time, that gene expression of
neuronal TRPC1 is decreased by all three anti-bipolar drugs.
Keeping in mind the similar effect in astrocytes, we may conceive
that TRPC1 may be a new therapeutic target for BD. It seems
that the decrease of TRPC1 gene expression and function
affects multiple neurotransmitters in neuronal cells. However, the
final conclusion of the pathophysiological relevance depends on
further understanding of TRPC1 function in neurones.
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